
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
PLEASE SUBMIT ALL RESUMES/CV'S IN ENGLISH FOR CONSIDERATION
Language RequirementFluent Spanish & English is Required
Preferred ExperiencePharmaceutical/Biotech Industry, Hematology, Oncology
General Description:
Reporting to the LATAM leadership, the Business Director is accountable for maximizing business performance across Region North – LATAM. The region operates under a Hub-and-Spoke model, with Colombia as the hub supporting the spoke markets of Peru, Ecuador, and CENCA. Based in Bogotá, Colombia, the role provides strategic and operational leadership across Sales, Marketing, Sales Effectiveness, Market Intelligence, Market Access, and Training, ensuring strong cross-functional alignment, operational excellence, effective stakeholder engagement, and compliant execution. The Business Director also oversees distributor performance in Spoke markets.
Essential Functions:
Minimum Requirements – Education and Experience:
Other Experience:
• Strong knowledge of the oncology landscape in Region North.
• Strong analytical, strategic, and leadership capabilities.
• Excellent communication and relationship-building skills.
• High motivation, resilience, and collaborative spirit.
• Fluency in Spanish and English.
Supervisory Responsibilities:
Travel:
Computer Skills:
#LI-Remote
Global Competencies
When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.
We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible.
To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.